Networks
Korean Government
Korea Drug Development Fund (KDDF) is a government-initiated drug development program backed by a collaborative effort of healthcare related Korean ministries.
Scientific Advisory Board
KDDF has utilized the Korean R&D community for project evaluation.
- The project embraces the full lifecycle of novel drug development from discovery to clinical stage.
- Evaluation committee members are updated regularly to maintain professional assessments.
- The KDDF evaluation committee consists of 693 members from academia, industry, public organizations, supported research institutes, and other professional fields.
Clinical Advisor
- Clinical trial specialists for each disease area provide consulting services.
Licensing Advisor
- Advisory board consisting of approximately seven executive-level advisors from global pharmaceutical companies.